629 related articles for article (PubMed ID: 30136733)
1. Drugs for treating Buruli ulcer (Mycobacterium ulcerans disease).
Yotsu RR; Richardson M; Ishii N
Cochrane Database Syst Rev; 2018 Aug; 8(8):CD012118. PubMed ID: 30136733
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of rifampicin-streptomycin for treatment of Buruli ulcer: a systematic review.
Tanywe A; Fernandez RS
JBI Database System Rev Implement Rep; 2017 Jan; 15(1):119-139. PubMed ID: 28085731
[TBL] [Abstract][Full Text] [Related]
3. Shortened treatment regimens versus the standard regimen for drug-sensitive pulmonary tuberculosis.
Grace AG; Mittal A; Jain S; Tripathy JP; Satyanarayana S; Tharyan P; Kirubakaran R
Cochrane Database Syst Rev; 2019 Dec; 12(12):CD012918. PubMed ID: 31828771
[TBL] [Abstract][Full Text] [Related]
4. Antimicrobial treatment for early, limited Mycobacterium ulcerans infection: a randomised controlled trial.
Nienhuis WA; Stienstra Y; Thompson WA; Awuah PC; Abass KM; Tuah W; Awua-Boateng NY; Ampadu EO; Siegmund V; Schouten JP; Adjei O; Bretzel G; van der Werf TS
Lancet; 2010 Feb; 375(9715):664-72. PubMed ID: 20137805
[TBL] [Abstract][Full Text] [Related]
5. Antibiotics versus no treatment for toxoplasma retinochoroiditis.
Pradhan E; Bhandari S; Gilbert RE; Stanford M
Cochrane Database Syst Rev; 2016 May; 2016(5):CD002218. PubMed ID: 27198629
[TBL] [Abstract][Full Text] [Related]
6. Successful outcomes with oral fluoroquinolones combined with rifampicin in the treatment of Mycobacterium ulcerans: an observational cohort study.
O'Brien DP; McDonald A; Callan P; Robson M; Friedman ND; Hughes A; Holten I; Walton A; Athan E
PLoS Negl Trop Dis; 2012 Jan; 6(1):e1473. PubMed ID: 22272368
[TBL] [Abstract][Full Text] [Related]
7. Rifampicin and clarithromycin (extended release) versus rifampicin and streptomycin for limited Buruli ulcer lesions: a randomised, open-label, non-inferiority phase 3 trial.
Phillips RO; Robert J; Abass KM; Thompson W; Sarfo FS; Wilson T; Sarpong G; Gateau T; Chauty A; Omollo R; Ochieng Otieno M; Egondi TW; Ampadu EO; Agossadou D; Marion E; Ganlonon L; Wansbrough-Jones M; Grosset J; Macdonald JM; Treadwell T; Saunderson P; Paintsil A; Lehman L; Frimpong M; Sarpong NF; Saizonou R; Tiendrebeogo A; Ohene SA; Stienstra Y; Asiedu KB; van der Werf TS;
Lancet; 2020 Apr; 395(10232):1259-1267. PubMed ID: 32171422
[TBL] [Abstract][Full Text] [Related]
8. Mefloquine for preventing malaria during travel to endemic areas.
Tickell-Painter M; Maayan N; Saunders R; Pace C; Sinclair D
Cochrane Database Syst Rev; 2017 Oct; 10(10):CD006491. PubMed ID: 29083100
[TBL] [Abstract][Full Text] [Related]
9. Primaquine at alternative dosing schedules for preventing relapse in people with Plasmodium vivax malaria.
Milligan R; Daher A; Graves PM
Cochrane Database Syst Rev; 2019 Jul; 7(7):CD012656. PubMed ID: 31274189
[TBL] [Abstract][Full Text] [Related]
10. Comparison of 8 weeks standard treatment (rifampicin plus clarithromycin) vs. 4 weeks standard plus amoxicillin/clavulanate treatment [RC8 vs. RCA4] to shorten Buruli ulcer disease therapy (the BLMs4BU trial): study protocol for a randomized controlled multi-centre trial in Benin.
Johnson RC; Sáez-López E; Anagonou ES; Kpoton GG; Ayelo AG; Gnimavo RS; Mignanwande FZ; Houezo JG; Sopoh GE; Addo J; Orford L; Vlasakakis G; Biswas N; Calderon F; Della Pasqua O; Gine-March A; Herrador Z; Mendoza-Losana A; Díez G; Cruz I; Ramón-García S
Trials; 2022 Jul; 23(1):559. PubMed ID: 35804454
[TBL] [Abstract][Full Text] [Related]
11. Rifamycins (rifampicin, rifabutin and rifapentine) compared to isoniazid for preventing tuberculosis in HIV-negative people at risk of active TB.
Sharma SK; Sharma A; Kadhiravan T; Tharyan P
Cochrane Database Syst Rev; 2013 Jul; 2013(7):CD007545. PubMed ID: 23828580
[TBL] [Abstract][Full Text] [Related]
12. Albendazole alone or in combination with microfilaricidal drugs for lymphatic filariasis.
Macfarlane CL; Budhathoki SS; Johnson S; Richardson M; Garner P
Cochrane Database Syst Rev; 2019 Jan; 1(1):CD003753. PubMed ID: 30620051
[TBL] [Abstract][Full Text] [Related]
13. Primaquine alternative dosing schedules for preventing malaria relapse in people with Plasmodium vivax.
Milligan R; Daher A; Villanueva G; Bergman H; Graves PM
Cochrane Database Syst Rev; 2020 Aug; 8():CD012656. PubMed ID: 32816320
[TBL] [Abstract][Full Text] [Related]
14. Antibiotics for treating human brucellosis.
Yousefi-Nooraie R; Mortaz-Hejri S; Mehrani M; Sadeghipour P
Cochrane Database Syst Rev; 2012 Oct; 10(10):CD007179. PubMed ID: 23076931
[TBL] [Abstract][Full Text] [Related]
15. Antibiotics and antiseptics for venous leg ulcers.
O'Meara S; Al-Kurdi D; Ologun Y; Ovington LG; Martyn-St James M; Richardson R
Cochrane Database Syst Rev; 2013 Dec; (12):CD003557. PubMed ID: 24363048
[TBL] [Abstract][Full Text] [Related]
16. Tamponade in surgery for retinal detachment associated with proliferative vitreoretinopathy.
Schwartz SG; Flynn HW; Wang X; Kuriyan AE; Abariga SA; Lee WH
Cochrane Database Syst Rev; 2020 May; 5(5):CD006126. PubMed ID: 32408387
[TBL] [Abstract][Full Text] [Related]
17. Endodontic procedures for retreatment of periapical lesions.
Del Fabbro M; Corbella S; Sequeira-Byron P; Tsesis I; Rosen E; Lolato A; Taschieri S
Cochrane Database Syst Rev; 2016 Oct; 10(10):CD005511. PubMed ID: 27759881
[TBL] [Abstract][Full Text] [Related]
18. Linezolid for drug-resistant pulmonary tuberculosis.
Singh B; Cocker D; Ryan H; Sloan DJ
Cochrane Database Syst Rev; 2019 Mar; 3(3):CD012836. PubMed ID: 30893466
[TBL] [Abstract][Full Text] [Related]
19. Six-month therapy for abdominal tuberculosis.
Jullien S; Jain S; Ryan H; Ahuja V
Cochrane Database Syst Rev; 2016 Nov; 11(11):CD012163. PubMed ID: 27801499
[TBL] [Abstract][Full Text] [Related]
20. Interventions for Old World cutaneous leishmaniasis.
Heras-Mosteiro J; Monge-Maillo B; Pinart M; Lopez Pereira P; Reveiz L; Garcia-Carrasco E; Campuzano Cuadrado P; Royuela A; Mendez Roman I; López-Vélez R
Cochrane Database Syst Rev; 2017 Nov; 11(11):CD005067. PubMed ID: 29149474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
